• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·CNC
Held by 4 Gurus
Share

Centene Corporation Stocks

$ 62.97Last Updated 24.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

$ 31.45B

$ 62.97
Key Takeaways

Risk factor

Very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Manager
Fund
Portfolio Weight (%)
Change
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Sign up, to see portfolios that hold this stock
Sign up, to see portfolios that hold this stock

Latest news

13.05.2026 16:00

David Einhorn offers five top turnaround stocks

03.07.2025 12:18

Centene collapsed 40% and crashed stocks in the health insurance sector. Should we buy on a downturn?

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Centene Corporation functions as a diverse, multinational healthcare organization, primarily dedicated to delivering a comprehensive range of programs and services to underinsured and uninsured individuals throughout the United States. Its Managed Care division provides extensive health plan coverage for people enrolled in various government-sponsored initiatives. These initiatives include Medicaid, the State Children's Health Insurance Program (SCHIP), long-term services and support, foster care, and specialized Medicare-Medicaid plans that cater to individuals dually eligible for both programs, as well as aged, blind, or disabled populations. The broad spectrum of benefits within these health plans encompasses primary and specialty physician care, inpatient and outpatient hospital services, emergency and urgent care, prenatal support, laboratory and X-ray diagnostics, and home-based primary care. Complementary services feature transportation assistance, vision and dental care, telehealth access, immunizations, specialty pharmacy, therapy, social work, nurse advisory support, and care coordination. Additionally, members are covered for prescriptions, limited over-the-counter medications, medical equipment, and essential behavioral health and substance abuse services. This segment also extends its offerings to commercial healthcare products for individuals and employer groups of various sizes. Centene's Specialty Services segment delivers a distinct set of solutions, including pharmacy benefits management (PBM), 24/7 nurse advice lines and after-hours support, vision and dental services, and staffing provisions for correctional systems and other government agencies. This division also serves beneficiaries eligible for the Military Health System. Its clientele for these specialized services spans state programs, correctional institutions, healthcare organizations, employer groups, and other commercial entities. The company delivers its healthcare services through an expansive network comprising primary and specialty care physicians, hospitals, and various ancillary providers. Established in 1984, Centene Corporation is headquartered in St. Louis, Missouri.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of CNC is 64 and suggests 0.594% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.06.2026 13:54

Triggers for Investors: What Could Trigger a Real Market Correction as Early as This Summer

25.06.2026 13:26

Legend, a small biotech company, wants to compete with Big Pharma. Wall Street has faith in it.

25.06.2026 13:09

Alibaba shares plummeted to a 16-month low amid the AI scandal involving Anthropic

25.06.2026 11:03

Top Stories This Morning: Micron Restores Market Confidence in the AI Boom; Iran Wants to Control the Strait of Hormuz

25.06.2026 09:00

Two More Key AI Researchers Want to Leave Google for Anthropic — Bloomberg

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026